Company / R&D per Share
Serina Therapeutics, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.56
FY2025
5-year range
$0.03 / $2.21
FY2021-FY2025
Trend
+57.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 7 years, ranging from $0.03 in FY2022 to $2.21 in FY2023.
Based on SEC 10-K filings.
1.56 in FY2025 with a 5-year CAGR of +58.4%.
Declined from $2.21 to $1.56 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +286.8%
- 5-Year CAGR
- +58.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 57.8% year-over-year.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | +57.8% |
| FY2024 | $0.99 | -55.2% |
| FY2023 | $2.21 | +8092.2% |
| FY2022 | $0.03 | -30.1% |
| FY2021 | $0.04 | -75.4% |
| FY2020 | $0.16 | -9.2% |
| FY2018 | $0.17 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026